YHB Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
8,398
-50
-0.6% -$5.85K 0.07% 168
2026
Q1
$1.02M Buy
8,448
+100
+1% +$11.5K 0.07% 170
2025
Q4
$879K Sell
8,348
-215
-3% -$20.2K 0.06% 180
2025
Q3
$719K Sell
8,563
-20
-0.2% -$1.65K 0.05% 186
2025
Q2
$679K Sell
8,583
-3,678
-30% -$292K 0.05% 190
2025
Q1
$1.1M Sell
12,261
-1,035
-8% -$96.6K 0.09% 149
2024
Q4
$1.32M Sell
13,296
-1,400
-10% -$144K 0.11% 139
2024
Q3
$1.67M Buy
14,696
+3,564
+32% +$423K 0.14% 133
2024
Q2
$1.38M Sell
11,132
-161
-1% -$20.7K 0.12% 138
2024
Q1
$1.49M Sell
11,293
-445
-4% -$54.9K 0.13% 134
2023
Q4
$1.28M Sell
11,738
-38
-0.3% -$3.94K 0.12% 132
2023
Q3
$1.21M Buy
11,776
+226
+2% +$24.4K 0.11% 138
2023
Q2
$1.33M Sell
11,550
-503
-4% -$57.1K 0.12% 136
2023
Q1
$1.28M Sell
12,053
-89
-0.7% -$9.61K 0.13% 137
2022
Q4
$1.35M Buy
12,142
+52
+0.4% +$5.32K 0.14% 127
2022
Q3
$1.04M Buy
12,090
+32
+0.3% +$2.86K 0.12% 138
2022
Q2
$1.1M Sell
12,058
-137
-1% -$12.1K 0.12% 139
2022
Q1
$1M Sell
12,195
-482
-4% -$38K 0.09% 160
2021
Q4
$972K Buy
12,677
+81
+0.6% +$6.45K 0.08% 169
2021
Q3
$946K Sell
12,596
-720
-5% -$54.8K 0.08% 165
2021
Q2
$1.04M Sell
13,316
-487
-4% -$36.2K 0.09% 165
2021
Q1
$1.02M Buy
13,803
+62
+0.5% +$4.57K 0.09% 164
2020
Q4
$1.07M Buy
13,741
+133
+1% +$10.2K 0.1% 157
2020
Q3
$1.08M Sell
13,608
-3,618
-21% -$283K 0.12% 150
2020
Q2
$1.27M Sell
17,226
-392
-2% -$29.5K 0.18% 97
2020
Q1
$1.29M Sell
17,618
-398
-2% -$31.3K 0.22% 89
2019
Q4
$1.56M Sell
18,016
-1,168
-6% -$95.9K 0.22% 91
2019
Q3
$1.54M Buy
19,184
+29
+0.2% +$2.32K 0.24% 90
2019
Q2
$1.53M Sell
19,155
-142
-0.7% -$10.9K 0.24% 93
2019
Q1
$1.53M Buy
19,297
+50
+0.3% +$3.74K 0.24% 98
2018
Q4
$1.4M Buy
19,247
+3,346
+21% +$236K 0.25% 97
2018
Q3
$1.08M Buy
15,901
+1
+0% +$64 0.16% 115
2018
Q2
$921K Sell
15,900
-130
-0.8% -$7.33K 0.15% 120
2018
Q1
$833K Sell
16,030
-599
-4% -$32.4K 0.14% 120
2017
Q4
$893K Sell
16,629
-556
-3% -$30.8K 0.15% 111
2017
Q3
$1.05M Sell
17,185
-4,696
-21% -$285K 0.19% 107
2017
Q2
$1.34M Buy
21,881
+4,278
+24% +$260K 0.23% 95
2017
Q1
$1.05M Buy
17,603
+49
+0.3% +$2.97K 0.2% 101
2016
Q4
$986K Buy
17,554
+4,602
+36% +$269K 0.21% 105
2016
Q3
$771K Sell
12,952
-2,374
-15% -$139K 0.19% 108
2016
Q2
$842K Buy
15,326
+6,770
+79% +$360K 0.19% 105
2016
Q1
$432K Sell
8,556
-5,060
-37% -$248K 0.12% 117
2015
Q4
$686K Sell
13,616
-1,082
-7% -$54.6K 0.16% 112
2015
Q3
$693K Sell
14,698
-496
-3% -$26.3K 0.16% 114
2015
Q2
$825K Buy
15,194
+1,845
+14% +$103K 0.18% 114
2015
Q1
$732K Buy
13,349
+144
+1% +$8.15K 0.16% 114
2014
Q4
$716K Buy
13,205
+299
+2% +$16.7K 0.16% 114
2014
Q3
$730K Buy
12,906
+739
+6% +$41.5K 0.18% 109
2014
Q2
$672K Buy
12,167
+655
+6% +$35.7K 0.16% 109
2014
Q1
$624K Buy
11,512
+361
+3% +$18.7K 0.16% 108
2013
Q4
$533K Sell
11,151
-3,966
-26% -$181K 0.14% 109
2013
Q3
$687K Sell
15,117
-105
-0.7% -$4.79K 0.2% 101
2013
Q2
$675K Buy
+15,222
New +$680K 0.21% 106

Other funds holding MRK

YHB Investment Advisors's MRK Position: Q2 2026 in Review

YHB Investment Advisors reduced its Merck (MRK) stake by 0.59% in Q2 2026, selling an estimated $5.85K and leaving 8,398 shares worth $1.08M. The position accounts for 0.07% of the portfolio, ranked #168.

YHB Investment Advisors first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.67M in Q3 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • YHB Investment Advisors held 8,398 shares of Merck worth $1.08M as of Q2 2026.
  • YHB Investment Advisors sold 50 Merck shares in Q2 2026, an estimated $5.85K.
  • Merck made up 0.07% of YHB Investment Advisors's portfolio in Q2 2026, its #168 holding.
  • YHB Investment Advisors first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • YHB Investment Advisors's Merck position peaked at $1.67M in Q3 2024.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on YHB Investment Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.